RS
Raghunandan Sharan Srivastava
About Raghunandan Sharan Srivastava
Data last updated:
Raghunandan Sharan Srivastava has 13 years in corporate governance. Holds Director role. Currently with 1 company, including Unex Remedies Private Limited. Engaged in General Business. Contributes to corporate operations. The largest current company by reported revenue is Unex Remedies Private Limited at ₹13.2 Lakh (FY 2020).
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
 Unex Remedies Private Limited U93030UP2013PTC057925 | Director | 24 Jun 2013 | 2013 | ₹13.2 Lakh (FY 2020) | Active |
Previous companies
Explore Director's current and past company associations Uncover their professional journey today!
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Raghunandan Sharan Srivastava
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Raghunandan Sharan Srivastava
Raghunandan Sharan Srivastava has 13 years in corporate governance. Holds Director role. Currently with 1 company, including Unex Remedies Private Limited. Engaged in General Business. Contributes to corporate operations. The largest current company by reported revenue is Unex Remedies Private Limited at ₹13.2 Lakh (FY 2020).
Raghunandan Sharan Srivastava is associated with 1 company as Director, including Unex Remedies Private Limited (₹13.2 Lakh).
Raghunandan Sharan Srivastava has expertise in General Business.
Raghunandan Sharan Srivastava has 13 years in corporate governance.
By reported revenue, the largest current company of Raghunandan Sharan Srivastava is Unex Remedies Private Limited, with revenue of ₹13.2 Lakh (FY 2020).
Raghunandan Sharan Srivastava currently holds positions at 1 company: Unex Remedies Private Limited (₹13.2 Lakh).